Issued Patents All Time
Showing 1–25 of 49 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12343393 | Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use | Thomas M. Lancaster, Thillainayagam Sathiyaseelan, Kexin Huang | 2025-07-01 |
| 12240881 | Ultra-long acting insulin-Fc fusion protein and methods of use | Thomas M. Lancaster | 2025-03-04 |
| 12195511 | Ultra-long acting insulin-Fc fusion protein | Thomas M. Lancaster | 2025-01-14 |
| 11919935 | Ultra-long acting insulin-Fc fusion proteins and methods of use | Thomas M. Lancaster | 2024-03-05 |
| 11814418 | Ultra-long acting insulin-Fc fusion protein and methods of use | Thomas M. Lancaster | 2023-11-14 |
| 11773151 | Ultra-long acting insulin-Fc fusion proteins and methods of use | Thomas M. Lancaster | 2023-10-03 |
| 11707517 | Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use | Thomas M. Lancaster, Thillainayagam Sathiyaseelan, Kexin Huang | 2023-07-25 |
| 11673934 | Ultra-long acting insulin-Fc fusion proteins and methods of use | Thomas M. Lancaster | 2023-06-13 |
| 11667689 | Insulin-Fc fusion proteins and methods of use to treat cancer | Thomas M. Lancaster | 2023-06-06 |
| 11555058 | Cells engineered to express ultra-long acting insulin-Fc fusion proteins | Thomas M. Lancaster | 2023-01-17 |
| 11359001 | Insulin-Fc fusions and methods of use | Thomas M. Lancaster, Thillainayagam Sathiyaseelan, Sylaja Murikipudi | 2022-06-14 |
| 11352407 | Ultra-long acting insulin-Fc fusion proteins | Thomas M. Lancaster | 2022-06-07 |
| 11267862 | Ultra-long acting insulin-Fc fusion proteins and methods of use | Thomas M. Lancaster | 2022-03-08 |
| 11261229 | Ultra-long acting insulin-Fc fusion proteins and methods of use | Thomas M. Lancaster | 2022-03-01 |
| 11213581 | Antigen specific immunotherapy for COVID-19 fusion proteins and methods of use | Thomas M. Lancaster, Thillainayagam Sathiyaseelan, Kexin Huang | 2022-01-04 |
| 11198719 | Ultra-long acting insulin-Fc fusion protein and methods of use | Thomas M. Lancaster | 2021-12-14 |
| 11192930 | Ultra-long acting insulin-Fc fusion protein and methods of use | Thomas M. Lancaster | 2021-12-07 |
| 11186623 | Ultra-long acting insulin-Fc fusion proteins and methods of use | Thomas M. Lancaster | 2021-11-30 |
| 10961294 | Ultra-long acting insulin-Fc fusion proteins and methods of use | Thomas M. Lancaster | 2021-03-30 |
| 10947292 | Ultra-long acting insulin-Fc fusion proteins and methods of use | Thomas M. Lancaster | 2021-03-16 |
| 10870686 | Ultra-long acting insulin-FC fusion proteins and methods of use | Thomas M. Lancaster | 2020-12-22 |
| 10851147 | Ultra-long acting insulin-Fc fusion proteins and methods of use | Thomas M. Lancaster | 2020-12-01 |
| 10597435 | Insulin-Fc fusions and methods of use | Thomas M. Lancaster, Thillainayagam Sathiyaseelan, Sylaja Murikipudi | 2020-03-24 |
| 10398781 | Conjugate based systems for controlled drug delivery | Thomas M. Lancaster | 2019-09-03 |
| 9745355 | Binding-site modified lectins and uses thereof | Thomas M. Lancaster | 2017-08-29 |